|
| |
Overview
Financial Highlight
Headlines
Business Background Sunway is a Malaysian property-construction corporation with business divisions in property, construction, hospitality, retail, leisure, commercial, trading and manufacturing, building materials, quarrying, healthcare, education, and a real estate investment trust. The property division develops residential and nonresidential properties including retail, healthcare, hospitality, leisure, and commercial assets. The construction division is involved in civil engineering, industrial building systems, geotechnical solutions, machinery, and logistics. The retail division owns and manages shopping malls. The hospitality division operates hotels and resorts in Malaysia, Cambodia, and Vietnam. The leisure division operates theme park attractions such as Sunway Lagoon in Bandar Sunway.
  Johncane Sunway is very strong.. i can see new building and new project are coming up 20/09/2019 10:45 AM Angrybird12345 If I sell my share on 27th Oct, i still entitle for the devidend ? 25/09/2019 10:18 PM martinbartesque sunway mother seems really good in chart. sunway-wb has 7sen step down every year. If not mistaken, 7sen step down will be adjusted on tomorrow. This means sunway-wb will become cheaper & worth to buy 02/10/2019 1:15 PM martinbartesque https://www.orientaldaily.com.my/news/business/2019/10/10/309950 医疗潜力未反映 双威可逢低买进 （吉隆坡10日讯）双威（SUNWAY，5211，主板工业股）旗下医疗业务前景乐观，惟分析员认为，医疗业务的潜力未全面反映在估值中。因此，目前的股价提供“逢低进场”机会。 丰隆投行分析员近期到访双威伟乐城（Sunway Velocity）医院后，对双威医疗业务前景感到正面乐观。 双威伟乐城医院9月3日开始营运，目前提供120张床位和45家诊所，已接待超过1000名病人。该医院预计将在2020年杪全面运作，届时将提供240张床位和77间诊所。 同时，医院采用电子医疗报告系统，将患者数据全面数码化，提升数据输入过程效率，进而缩减患者的等待时间。 值得一提的是，该医院接生的第一位婴儿是中国公民，可见双威医疗获得外国人的信赖。 另一边厢，位于双威城的旗舰医院--双威医疗中心，正展开第4阶段扩建工程，计划2020年完工，届时将可容纳更多的专科诊所和床位。 正如双威伟乐城医院，双威医疗中心也将迎来数码化改革，将原先的打印报告，转为电子报告。 无论如何，分析员指出，按照估值比较，IHH医疗保健集团（IHH，5225，主板保健股）和柔佛医药保健（KPJ，5878，主板保健股）本益比分别是37倍和19倍，双威仅达12倍本益比，提供投资者低价进场的机会。 医疗业务或上市 此外，双威医疗业务或分拆挂牌上市，以2018财政年（12月31日结账）净利和25倍本益比计算，估值约15亿令吉。考虑到双威计划未来3年内陆续增设4家新医院，随著业务扩展，估值也随之扬升。 总结来说，基于产业和建筑发展业务相互扶持，取得完美结合，其估值也未全面反映医疗业务，加上旗下建材和采石业务也处在不断增长阶段，双威依然是分析员的首选股。 分析员维持双威“买进”投资评级，目标价为2.17令吉。双威周四闭市报1.64令吉，无起落 11/10/2019 8:56 AM martinbartesque Sunway - Healthcare Gaining Traction Author: HLInvest | Publish date: Thu, 10 Oct 2019, 8:44 AM Sunway Medical Centre Velocity, the latest addition to Sunway’s healthcare arm started operations on 3 Sep 2019, receiving over 1,000 patients since then. The hospital has a capacity of 240 beds and 77 specialist clinics once fully operational by end-2020. Meanwhile, Sunway Medical Centre (located in Bandar Sunway) is currently undergoing its Phase 4 expansion (targeted to complete by 2022), which will house additional specialist clinics, an assisted living centre and additional hospital beds. We maintain our forecast and BUY rating with an unchanged TP of RM2.17 based on a 10% holding discount from SOP-derived valuation of RM2.41. We took a group of fund managers/analysts to visit the Sunway Medical Centre Velocity (SMCV). The MD of healthcare unit, CEO of Velocity Hospital and management team took us round the various units. We came out feeling positive about its prospects. Here are the key takeaways. SMCV. The hospital did its soft launch on 3 Sept and is located in a 10-storey building next to the Sunway Velocity Mall and Hotel. The hospital has a capacity of 240 beds and 77 specialist clinics once fully operational by end-2020. As a start, it currently operates on 120 beds with 45 clinics and since its soft launch, it has received over 1,000 patients. Interestingly, the first baby delivered on the maternity ward was a Chinese national, anecdotally indicating its attractiveness to foreigners. The hospital runs an e-Medical Report system whereby data of patients are all digitalized, allowing for more efficient data processing and reducing the waiting time before and during consultations. The hospital has attracted doctors with an equal mix from both the private and government sectors. Sunway Medical Centre (SMC). Located in Bandar Sunway, Sunway’s flagship hospital is currently undergoing its Phase 4 expansion (targeted to complete by 2022), which will house additional specialist clinics, an assisted living centre and additional hospital beds. SMC is also migrating its data system to e-Medical Report from its conventional physical report cards. Cheaper entry to the healthcare sector via Sunway Berhad (trading at forward P/E of 12x) as compared to IHH (37x) and KPJ (19x). With the listing of the healthcare business potentially on the cards, Sunway’s healthcare business is estimated to fetch a valuation of c.RM1.5bn (based on FY18 net profit and a price multiple of 25x), with further upside as expansion of the business is ongoing. Forecast. Unchanged as the meeting yielded no major surprises. Maintain BUY with an unchanged TP of RM2.17 based on a 10% holding discount from SOP-derived valuation of RM2.41. Sunway remains our top pick given its well integrated property and construction development. Its hidden gem, the healthcare business (with 4 new hospitals coming on stream over the next three years) has yet to be appreciated as it is embedded within the parent-co. These coupled with the resilient earnings from mature investment properties alongside its growing building materials business and quarry operations justifies for the re-rating of the stock. Source: Hong Leong Investment Bank Research - 10 Oct 2019 11/10/2019 9:02 AM martinbartesque https://www.enanyang.my/news/20191010/%E3%80%90%E8%A7%86%E9%A2%91%E3%80%91%E5%8F%8C%E5%A8%81-%E5%8C%BB%E7%96%97%E4%B8%9A%E5%8A%A1%E6%88%96%E7%8B%AC%E7%AB%8B%E4%B8%8A%E5%B8%82/ 双威（SUNWAY，5211，主板工业股）最新的蕉赖双威伟乐医疗中心，在上月3日非正式推介，至今接收了超过1000名病患；在明年杪全面运作后，该医院会完全开放240张床位和77间专科诊所。 另外，双威医疗中心正进行第四期扩建，放眼2022年竣工，届时将增添额外专科诊所、床位和一所生活辅助中心。 行家建议 我们先前拜访了双威伟乐医疗中心，对该医院的前景感到有信心。 我们视双威为投资医疗领域的最廉宜途径，目前股价以本益比是12倍，远低于IHH医疗保健集团（IHH，5225，主板保健股）的37倍，及柔佛医药保健（KPJ，5878，主板保健股）的19倍。 目前，双威医疗业务仍有可能独立上市，预计估值约可达15亿令吉，相当于2018财年本益比的25倍，且还有上升空间，因为扩展计划正如火如荼。 不过，由于此次会面没有重大惊喜，因此我们维持财测不变。 我们保持“买入”评级和2.17令吉目标价，相当于加总估值法（SOP）得出的2.41令吉再折价10%。 此外，鉴于双威良好的整合产业发展与建筑业务，该公司仍是我们的首选股，且未被发掘的医疗业务，尚未获得投资者赏识。 11/10/2019 9:05 AM martinbartesque Assuming the listing of healthcare becomes true, and share price of Sunway is increased from 1.69 to 2.00 where WB maintains premium of 26%, WB will be worth RM0.80 based on calculation. Decide on your own whether it is worth to buy & keep WB :) 11/10/2019 9:18 AM martinbartesque Listing of healthcare has been delayed, not in 2019? Probably it is no longer in 2019 as now is almost end of 2019. Would it probably be in 2020? I believe so. Do your own judgement. https://www.thestar.com.my/business/business-news/2017/06/15/sunway-set-to-list-healthcare-arm-in-2019 11/10/2019 10:07 AM RainT Listing the healthcare unit of SUNWAY then we as SUNWAY shareholders what we will get? free shares of the SUNWAY healthcare unit ? 17/10/2019 7:06 PM  necro Yup... Dividend in specie... Most likely 1 Sunway Healthcare for 1 Sunway... 18/10/2019 5:38 PM RainT same as usual sleeping in the same range SUNWAY pattern is like that as most of the shares in control by major funds and shareholders 30/10/2019 8:26 PM  Mabel 01/11/2019 1.70 1.78 +0.08 (4.71%) HOLD TA 01/11/2019 1.70 2.17 +0.47 (27.65%) BUY HLG 29/10/2019 1.69 1.78 +0.09 (5.33%) HOLD TA 29/10/2019 1.69 1.99 +0.30 (17.75%) BUY AmInvest 23/10/2019 1.69 2.17 +0.48 (28.40%) BUY HLG 17/10/2019 1.69 2.17 +0.48 (28.40%) BUY HLG 10/10/2019 1.69 2.17 +0.48 (28.40%) BUY HLG 09/10/2019 1.68 1.78 +0.10 (5.95%) HOLD TA 23/09/2019 1.68 1.78 +0.10 (5.95%) HOLD TA 23/09/2019 1.68 1.99 +0.31 (18.45%) BUY AmInvest Lovely price target... Managed to accumulate more... Thanks for selling... See you all at RM 3... Cheers! 04/11/2019 10:01 AM necro what happen?...already break resistant RM1.74... Sunway Healthcare IPO on the pipeline? Superb quarter result on 21/11/2019? Another M&A on the way? or SUNREIT good result? 06/11/2019 11:13 AM mcmann hard to say tomorrow will up or not recently many post good qr the next thing is drop hmmm 21/11/2019 7:39 PM RainT that is KLSE pattern good result but share price no go up or stagnant instead 22/11/2019 3:18 PM zakaria444 Sunway Bhd’s (Sunway) net profit in the third-quarter (Q3) ended September 30, 2019, rose 26.57 per cent to RM183.42 million from RM144.92 million recorded a year ago. 22/11/2019 3:26 PM prince4 US-CHINA Trade War market uncertain, local and foreign funds money would not flow in big cap and mid cap stock because everybody scare buy high losses money . In this few month expect Funds manager money would flow out in big cap and midcap stocks and will short selling mid cap stocks for make money so now no prospects cannot buy and hold . http://www.bursamalaysia.com/misc/system/assets/28273/Directive-on-the-List-of-Approved-Securities-(with-effective-from-29Nov2019).pdf TOP volume all low prices stocks.This is a opportunity ,markets money now flows in cheaper stocks. sharks now start goreng lows price stock at bottom.. 29/11/2019 3:40 PM 93126668 https://www.theedgemarkets.com/article/higher-fy20-earnings-expected-sunway 06/12/2019 4:47 PM  |
|
